Breville Group Ltd (ASX: BRG) shares could be undervalued according to Ord Minnett.

On Thursday, the appliance manufacturer’s shares ended the session at $26.52.

This means the ASX 200 stock is down almost 30% from its high.

What is the broker saying about this ASX 200 stock?

Ord Minnett is very positive on Breville right now. This is partly due to its expansion in the United States, which has been boosted by a recent consolidation of vendors by Best Buy (NYSE: BBY). It explains:

Breville executed a major US retail expansion in late 2025 where it installed ‘store-in-store’ formats in 300 of the more than 1,000 stores operated by US big-box consumer electronics retailer Best Buy. This was part of a deliberate consolidation of vendors by Best Buy, which has rationalised its small domestic appliance offering to five brands – three primary brands in Breville, Dyson and SharkNinja and two secondary brands in De’Longhi and Bella – although brands outside that range can still sell through Best Buy’s Marketplace online channel.”

A structural advantage in a key market

The broker believes this shift in the retail landscape could work strongly in Breville’s favour. Ord Minnett explains:

The consolidation of vendors by Best Buy is described by Breville management as a “material change” to the retail channel structure in the US. The brands chosen benefit from additional shelf space and a structural lock-in, while the brands that have been de-ranged lose access to more than 1,000 retail locations. This dynamic is also playing out across other Best Buy categories, not just small domestic appliances.

As a result, the ASX 200 stock appears to be gaining a stronger competitive position in a highly important market.

Should you buy this ASX 200 stock?

According to the note, the broker has put a buy rating and $37.20 price target on Breville’s shares.

Based on its current share price, this implies potential upside of 40% for investors over the next 12 months.

In addition, a dividend yield of approximately 1.5% is expected over the period.

The broker concludes:

As a primary partner in Best Buy’s consolidated vendor strategy, this should provide Breville with a significant competitive advantage in the giant US market. Following recent weakness in the Breville share price, we upgrade to Buy from Accumulate with an unchanged price target of $37.20.

The post Ord Minnett says this ASX 200 stock can rise 40% appeared first on The Motley Fool Australia.

More reading

• Buy, hold, sell: Breville, Collins Foods, and MA Financial shares
• Buy, hold, sell: Breville, Goodman, and Wesfarmers shares
• How high does Macquarie think Breville shares will go?
• Leading brokers name 3 ASX shares to buy today
• Why buying ASX shares in March could supercharge your wealth

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has positions in and has recommended Best Buy. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

The amount of superannuation you need to retire at age 70 depends almost entirely on the type of lifestyle you expect to have in retirement.

In Australia, your retirement is generally split into two options: modest and comfortable. Both assume you own your home outright.

What is a modest retirement, and how much does it cost?

A modest retirement, according to the Association of Superannuation Funds of Australia (ASFA), is defined as being able to cover expenses slightly above the full Centrelink Age Pension.

This includes basic health insurance with limited cap payments, a cheaper model of car, and infrequent exercise. It also includes a limited home repair budget, minimal utility expenses, limiting dining out, and maybe an annual domestic trip. 

Unfortunately, thanks to the rising cost of living, the benchmark for a modest retirement has just climbed higher. Australians now need $35,503 per year, or $51,299 per year for a couple.

To fund that, ASFA estimates you need a superannuation balance of around $110,000, or a couple would need $120,000.

What is a comfortable retirement, and how much does it cost?

A comfortable retirement lifestyle is defined as one that allows Australians to maintain a good standard of living. 

This includes top-level private health insurance, ownership of a reasonable car brand, regular leisure activities, funds for home repairs and renovations, occasional meals out, and an annual domestic trip.

Again, the benchmark for a comfortable retirement has also recently increased. Now, Australians need $54,840 a year, or $77,375 a year for a couple.

That lifestyle requires a superannuation balance of around $630,000 for a single person, or $730,000 for a couple.

The benefits of waiting until age 70 to retire

Many government or association estimates around retirement are based on the understanding that you’ll retire at age 67. 

Age 67 is also when you’re eligible for the age pension.

While this is around the average retirement age in Australia, there are significant benefits to delaying retirement by just a couple of years.

Rising cost of living, higher health and transport costs, and a longer life span will all see you eat away at your superannuation balance much more quickly.

Retiring at age 70 gives you time to build more superannuation, and it means there are fewer retirement years to fund. After all, even 3 to 5 years would raise your superannuation balance and also give your investments more time to grow.

Superannuation funds are heavily invested in the Australian share market, particularly the S&P/ASX 200 Index (ASX: XJO). Over long periods of time, the ASX 200 generally delivers positive returns. That means the longer you wait to access your balance, the more time your balance has to benefit from compounding growth. 

Great, so how do I know if my superannuation is on track?

According to ASFA, for a comfortable retirement, your superannuation balance at age 40 should be $178,000. 

By age 50, this should be around $313,500, and it should be close to $496,500 by age 60. 

By your late 60s to early-70s, you need to be at or close to your superannuation goal of $630,000 to $730,000 (for a couple) if you want to retire comfortably.

The post Here’s how much superannuation you need to retire at age 70 appeared first on The Motley Fool Australia.

More reading

• Down 65%: Are Pro Medicus shares in the buy zone yet?
• 6 ASX shares at 52-week lows: Buy, hold, or sell?
• Here are the top 10 ASX 200 shares today
• Are Liontown shares a buy, hold, or sell?
• This ASX retail giant’s shares just hit a record low. What’s going on?

Motley Fool contributor Samantha Menzies has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

It’s no secret that the past few weeks have been tough for most ASX investors. At least those without a portfolio full of energy stocks. Since the beginning of March, the S&P/ASX 200 Index (ASX: XJO) has dropped by more than 7%, which is a fairly hefty fall for four weeks’ worth of trading. But let’s talk about the journey that Pro Medicus Ltd (ASX: PME) shares have had.

At first glance, it doesn’t look as though Pro Medicus’ share price has fared any worse than the broader market. The medical imaging tech stock has retreated by 6.15% since 2 March, just under the 6.2% the ASX 200 has shed over that same period.

This ASX stock has had a tough few months…

But if we zoom out, the picture gets a lot bleaker for Pro Medicus investors. This ASX tech stock last peaked in July last year, hitting a new record high of $336. Ever since then, it has been down and down for the company. At today’s share price (at the time of writing) of $118.11, Pro Medicus is down a horrid 64.85% from that high. That would have come as quite a shock to investors in this company, who, barring market-wide sell-offs, have largely had to sit back and watch it go up and to the right for years now.

It’s not like Pro Medicus has given investors an obvious reason to hit the sell button either. Back in February, the company posted its latest half-year results, which were hard to fault. Pro Medicus reported revenue growth of 28.4% to $124.8 million for the six months to 31 December. Underlying profits were up an even more impressive 29.7% to $90.7  million. That allowed the company to hike its interim dividend by a whopping 28% to 32 cents per share. Pro Medicus has also continued to announce new contract signings regularly.

So, given all this, many investors might be wondering whether Pro Medicus shares offer a compelling ‘buy-the-dip’ opportunity right now.

Down 65%: Is it time to buy Pro Medicus shares?

Almost every ASX broker covering this company agrees that the Pro Medicus sell-down represents a lucrative buying opportunity.

Last week, my Fool colleague discussed Morgans’ ‘buy’ rating for the company, which included a 12-month share price target of $275. That’s more than a doubling of where the shares are today. The broker commented that “the [market] reaction feels overcooked and the setup into 2H is far better than the share price implies”.

Another broker, Bell Potter, agrees. It currently has a $240 target on Pro Medicus shares and recently stated, “The company continues to announce new contract wins on a regular basis as the drivers of interest in its product offering remain firmly in place.”

Of course, we’ll have to see if these brokers are on the money. But Pro Medicus’ stunning growth and strong fundamentals do, arguably, make this a stock well worth a deeper dive whilst it is trading at this steep discount.

The post Down 65%: Are Pro Medicus shares in the buy zone yet? appeared first on The Motley Fool Australia.

More reading

• Where to invest $10,000 in ASX shares right now
• The ASX healthcare stocks with the biggest upside according to brokers
• Buy, hold, sell: NAB, Pro Medicus, and Telstra shares
• This could be a once-in-a-decade opportunity to buy cheap ASX tech stocks
• Forget CSL shares, this ASX healthcare stock could double in value

Motley Fool contributor Sebastian Bowen has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has recommended Pro Medicus. The Motley Fool Australia has recommended Pro Medicus. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

S&P/ASX All Ords Index (ASX: XAO) shares finished 0.21% lower on Thursday as the war in Iran continued.

At the close, 291 of the 500 ASX All Ords shares had fallen throughout the day, with several hitting new 52-week lows.

Are these stocks a buying opportunity?

Let’s defer to the experts.

Endeavour Group Ltd (ASX: EDV)

The Endeavour share price fell to a 52-week low of $3.36 on Thursday.

Endeavour shares have tumbled 12% over the past 12 months.

After reviewing Endeavour’s 1H FY26 report, Morgans maintained a hold rating on this ASX consumer staples share.

However, the broker reduced its 12-month price target slightly from $3.70 to $3.65.

Morgans said:

While EDV continues to work on its refreshed strategy with further details to be provided at an investor day on 27 May, management confirmed that the combined Retail and Hotels portfolio will be retained.

Management also noted that they will continue investing in Dan Murphy’s to restore its price leadership, while accelerating hotel renewals and electronic gaming machine (EGM) replacements.

Objective Corporation Ltd (ASX: OCL)

The Objective Corporation share price fell to a 52-week low of $11.67 today.

The ASX tech share is down 22% over the past year.

Morgans recently changed its rating from accumulate to buy but lowered its 12-month target from $20 to $16.70.

The broker commented:

We see tailwinds remaining supportive of OCL’s long-term growth momentum.

Treasury Wine Estates Ltd (ASX: TWE)

This ASX wine share fell to a multi-year low of $3.34 on Thursday.

Treasury Wine Estates has lost two-thirds of its market capitalisation over the past year.

This week, Jefferies retained its hold rating on Treasury Wine shares and lowered its target from $5 to $4.

Dexus Industria REIT (ASX: DXI)

This real estate investment trust (REIT) fell to a 52-week low of $2.32 on Thursday.

The Dexus Industria REIT share price has declined 14% over the past year.

Bell Potter has a buy rating on Dexus Industria stock with a share price target of $3.

Nuix Ltd (ASX: NXL)

The Nuix share price fell to a 52-week low of $1.24 today.

This ASX tech share has crumbled 62% over the past 12 months.

Morgan Stanley has a buy rating on Nuix shares with a 12-month target of $3.75.

DigiCo Infrastructure REIT (ASX: DGT)

DigiCo shares fell to a 52-week low of $1.67 on Thursday.

The DigiCo Infrastructure REIT share price has halved over 12 months.

This week, Morgans reiterated its buy rating but slashed its price target from $4.15 to $2.70.

The post 6 ASX shares at 52-week lows: Buy, hold, or sell? appeared first on The Motley Fool Australia.

More reading

• This ASX retail giant’s shares just hit a record low. What’s going on?
• Treasury Wine shares just tumbled to 14-year lows. Screaming bargain or falling knife?
• 3 top blue-chip ASX 200 shares that look dirt cheap right now
• 3 ASX dividend shares yielding 5%+ that still have growth potential
• 5 excellent ASX shares to buy for a retirement portfolio

Motley Fool contributor Bronwyn Allen has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has positions in and has recommended Objective and Treasury Wine Estates. The Motley Fool Australia has positions in and has recommended Objective and Treasury Wine Estates. The Motley Fool Australia has recommended Nuix. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

The S&P/ASX 200 Index (ASX: XJO) couldn’t hold on to the positive momentum we saw yesterday during this Thursday’s session.

Despite several stints in green territory this morning, the ASX 200 ended up closing in the red by the time trading wrapped up this afternoon, dropping 0.1%. That leaves the index at 8,525.7 points.

This miserly day for Australian investors follows a far more optimistic morning on Wall Street.

The Dow Jones Industrial Average Index (DJX: .DJI) was in fine form, rising by 0.66%.

The tech-heavy Nasdaq Composite Index (NASDAQ: .IXIC) did even better, gaining a rosy 0.77%.

But time to return to the local markets now and see how today’s falls were distributed amongst the different ASX sectors today.

The post Here are the top 10 ASX 200 shares today appeared first on The Motley Fool Australia.

More reading

• Why Catapult, DroneShield, Infratil, and Qoria shares are charging higher today
• Which data centre operator just upgraded its earnings outlook?
• Catapult Sports delivers strong FY26 growth and profitability
• Droneshield shares rocket 20% higher: What has happened?
• Vault Minerals: KoTH plant upgrade commissioning kicks off

Motley Fool contributor Sebastian Bowen has positions in CSL. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has positions in and has recommended CSL and DroneShield and is short shares of DroneShield. The Motley Fool Australia has recommended CSL and Elders. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

Liontown Ltd (ASX: LTR) shares are a popular option for investors looking at the lithium industry.

But are they a good option? Let’s see what analysts at Ord Minnett are saying about the lithium miner.

What is the broker saying?

Ord Minnett was pleased with the company’s performance during the first half of FY 2026, highlighting that its net loss was smaller than expected. It said:

Liontown posted an underlying first-half FY26 net loss that was smaller than market expectations, as reduced tax charges and benefits from non-cash inventory movements outweighed higher-than-anticipated depreciation and amortisation (D&A) expenses, while the rest of the result was as expected.

In addition, it notes that the company has reaffirmed its production guidance for FY 2026 and hit a 1.5 million tonnes per annum run rate. But it won’t be stopping there, with the company looking to grow its production to 2.8 million tonnes per annum next year.

At the same time, Liontown is expecting to reduce its unit costs meaningfully, which leaves it well-placed to generate material free cash flow at current prices. Ord Minnett said:

The lithium miner reiterated FY26 production guidance for the Kathleen Valley project in Western Australia and for the project to reach a run rate of 1.5 million tonnes per annum (Mtpa) of spodumene concentrate by the end of the March quarter this year, before rising to a run rate of 2.8Mtpa by the end of the June quarter in 2027.

The company forecasts reduced unit costs – $855–1045 per tonne on a 5.2% lithium oxide basis (SC5.2) versus market and Ord Minnett expectations of $913 per tonne and $934 per tonne, respectively– as the underground mining operation contributed the largest proportion of ore, rather than the open pit, by the end of FY26. Liontown sees a consistent recovery rate of circa 70% once the underground ore becomes the main feedstock.

Should you buy Liontown shares?

According to the note, the broker has put an accumulate rating on Liontown shares with a $1.90 price target.

Based on its current share price of $1.71, this implies potential upside of 11% for investors over the next 12 months. It concludes:

Post the result, we have cut our EPS estimates by 12.0% to incorporate increased finance costs and higher D&A charges, while our FY27 and FY28 forecasts are trimmed by 2.4% and 3.0%, respectively, to account for increased selling, general and administrative(SGA) expenses with a partial offset from reduced lease payments. We maintain our target price of $1.90 but have raised our recommendation to Accumulate from Hold on valuation grounds.

The post Are Liontown shares a buy, hold, or sell? appeared first on The Motley Fool Australia.

More reading

• 3 ASX mining shares: Buy, hold, or sell?
• Here are the top 10 ASX 200 shares today
• Are these 3 ASX 200 mining shares a buy, hold, or sell?
• 4 of the best ASX mining stocks to buy in the current environment
• Buy, hold, sell: Copper, gold, and lithium ASX stocks

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

The Endeavour Group Ltd (ASX: EDV) share price is continuing to fall again on Thursday.

At the time of writing, the company’s shares are down 1.17% to $3.39. This marks 6 consecutive sessions in the red for the embattled drinks group.

Notably, earlier in today’s session, the stock fell to $3.38, hitting a fresh record low.

The latest move adds to a weak run in 2026, with Endeavour shares now down around 7% since the start of the year.

Here’s what investors are seeing.

Pressure builds after recent results

The recent weakness follows the company’s half-year results, which highlighted mixed operating trends.

Group sales rose 0.9% to $6.7 billion. However, profitability moved in the opposite direction. Underlying net profit after tax (NPAT) fell 6.7% to $278 million, while statutory profit dropped 17.1% to $247 million.

The company also cut its interim dividend by 13.6% to 10.8 cents per share.

Margins remain under pressure as the business invests in pricing to stay competitive.

Management has been clear that price leadership is a focus, especially across its core retail brands. While this is supporting volumes, it is weighing on near-term earnings.

Brokers take a conservative stance

Broker updates following the result have been broadly neutral.

According to recent commentary, there were no major surprises in the numbers, with performance largely in line with earlier trading updates.

However, outlook changes have been modestly negative. One broker trimmed its EBIT forecasts for FY26 to FY28 by up to 4% and lowered its price target to around $3.65, while maintaining a hold rating.

The key takeaway across updates is that earnings are expected to remain under pressure as the company continues to invest in pricing and its hotel network.

What the chart is showing

From a technical view, the trend line remains weak.

The share price is trading near the lower end of its bollinger band range, which is suggesting sustained selling pressure.

Momentum indicators also point to a soft setup. The relative strength index (RSI) is sitting in the mid-40s, telling us the stock is neither oversold nor showing signs of strong buying interest.

With the stock now at record lows, there is limited visible support below current levels. Previous price action suggests the $3.80 to $4 range may now act as resistance.

Foolish Takeaway

Endeavour shares are continuing to drift lower following a soft earnings update and a cautious broker outlook.

The business remains focused on improving competitiveness through pricing and investment across its retail and hotel operations.

However, this strategy is weighing on margins in the near term, as reflected in both earnings trends and the share price.

The post This ASX retail giant’s shares just hit a record low. What’s going on? appeared first on The Motley Fool Australia.

More reading

• 5 excellent ASX shares to buy for a retirement portfolio
• 3 blue-chip ASX shares to boost your retirement income
• Buy, hold, sell: Brainchip, CAR Group, and Endeavour shares
• Buy, hold, sell: Collins Foods, Endeavour, and Magellan shares
• Could DroneShield shares double again in 2026?

Motley Fool contributor Aaron Teboneras has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

The Woolworths Group Ltd (ASX: WOW) share price is edging higher on Thursday, rising 0.60% to $36.60.

The gain further adds to a strong run this year, with Woolworths shares now up around 24% in 2026.

Today’s move comes as new details emerge around a significant property deal involving the sale of multiple shopping centres by the supermarket giant.

Let’s take a closer look at the media report.

$500 million property deal comes into focus

According to The Australian, Woolworths has agreed to sell a portfolio of 10 neighbourhood shopping centres. The portfolio is being acquired by investment firm Forest Endeavour for more than $500 million.

The portfolio includes supermarket-anchored retail sites across multiple states, with a mix of operating assets and some still under development.

Woolworths is expected to remain the anchor tenant across the locations.

Why Woolworths is selling these assets

This deal shows how Woolworths is managing its capital.

By selling the property but keeping its stores in place, the company can bring in cash without changing how it operates day-to-day.

That cash can then be used in other parts of the business, such as store upgrades, logistics improvements and technology investments.

It also means less money is tied up in owning property over the long-term.

Woolworths’ director of property development, Andrew Loveday, said the group has seen strong demand for supermarket-linked assets, highlighting the value of its property portfolio.

Why investors want these assets

This deal also reflects what is happening in the property market.

Shopping centres with major supermarkets are seen as more reliable because they bring steady foot traffic and consistent spending on everyday items.

The report notes that both local and offshore investors have been active in this space, looking for stable and predictable income.

Forest Endeavour, backed by Asian investors, has been growing its presence in Australian retail and hospitality assets.

The portfolio covers sites from Queensland to Tasmania and includes a mix of open-air centres and development projects.

Foolish bottom line

While the company is focusing on using its capital more efficiently, its core supermarket network remains unchanged.

In addition, by selling property but remaining the tenant, Woolworths can reduce capital tied up in long-term assets and improve financial flexibility.

The share price has already been trending higher this year, and moves like this show what’s driving it.

Woolworths currently has a market capitalisation of around $44.6 billion and sits among the top 20 companies listed on the ASX.

The post A $500 million deal just dropped for Woolworths. Here’s what investors need to know appeared first on The Motley Fool Australia.

More reading

• 1 ASX dividend stock and 1 growth stock I’d buy today
• Which defensive ASX shares are outperforming right now?
• A dependable ASX dividend stock to buy with $20,000 right now
• 5 excellent ASX shares to buy for a retirement portfolio
• 3 blue-chip ASX shares to boost your retirement income

Motley Fool contributor Aaron Teboneras has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has positions in and has recommended Woolworths Group. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

Treasury Wine Estates Ltd (ASX: TWE) shares are sinking today.

Shares in the S&P/ASX 200 Index (ASX: XJO) global wine company closed yesterday trading for $3.54. In afternoon trade on Thursday, shares are changing hands for $3.38 apiece, down 4.5%.

For some context, the ASX 200 is down 0.2% at this same time.

This will come as unwelcome news to the company’s shareholders, though not to the host of short sellers betting against the stock. Treasury Wine kicked off the week as the third most shorted stock on the ASX, with a short interest of 15.1%.

Unfortunately for those faithful stockholders, today’s underperformance is far from unusual for the wine company.

Indeed, following today’s slump, you’d have to go back to March 2012 to find Treasury Wine shares trading at a lower level.

What’s been pressuring the ASX 200 stock?

Treasury Wine shares have been in a downward trend for more than a year, with the stock down 65.7% over the past 12 months.

The company has faced a number of headwinds, including tougher trading conditions in some of its core markets, such as China and the United States.

Consumer drinking habits are also changing, with a shift in focus towards more premium-oriented wines.

These headwinds were apparent when the company released its half-year results (H1 FY 2026) on 16 February.

Net sales revenue of $1.3 billion was down 16% year on year, while earnings before interest and tax declined by 39.6% from H1 FY 2025 to $236.4 million. And with the company posting a statutory net loss of $649.4 million, management suspended the Treasury Wine dividend.

Treasury Wine shares closed down 5.2% on the day of the results release.

Are Treasury Wine shares now on sale?

It’s never easy trying to call the bottom on a stock that’s lost two-thirds of its value in a year.

According to consensus analyst recommendation on CommSec, the ASX 200 wine company is a hold, with two strong buy recommendations, two moderate buy recommendations, 11 hold recommendations, and two strong sell recommendations.

There are a few reasons I’m modestly optimistic about the potential for a material turnaround over the medium term.

Among them, the company’s shifting focus to premium brands and its Project Ascent program. This program aims to achieve $100 million in annual cost savings over two to three years.

Commenting on the program, CEO Sam Fischer said:

It is a disciplined, multi-year transformation program designed to sharpen our portfolio, simplify the organisation and optimise our cost base, and I am pleased with the progress we have made to date.

Also, while I’m not prone to mimicking the investments made by billionaires, I do tend to take note.

And on that note, news emerged in early March that French billionaire Olivier Goudet had invested another $41.7 million in Treasury Wine shares since mid-January. That sees Goudet holding around 7.1% of the company’s outstanding shares.

The post Treasury Wine shares just tumbled to 14-year lows. Screaming bargain or falling knife? appeared first on The Motley Fool Australia.

More reading

• 3 top blue-chip ASX 200 shares that look dirt cheap right now
• These are the 10 most shorted ASX shares
• These are the 10 most shorted ASX shares
• Why I’d buy these dirt-cheap ASX 200 shares trading at 52-week lows
• Growth, value, dividends: 1 ASX stock in each category to buy immediately

Motley Fool contributor Bernd Struben has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has positions in and has recommended Treasury Wine Estates. The Motley Fool Australia has positions in and has recommended Treasury Wine Estates. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

4DMedical Ltd (ASX: 4DX) shares have jumped another 2.3% higher in Thursday afternoon trade. At the time of writing, the shares are changing hands at $6.37 a piece.

The uptick means the shares have now rocketed 55% over the past week. They’re now up a huge 71% over the past month and are 40% higher over the year to date.

Most impressively, 4DX shares are 1,890% higher than this time 12 months ago, driven by regulatory approvals and a portfolio of signed contracts with hospitals and medical providers.

The ASX healthcare technology company develops imaging software for healthcare providers to analyse airflow through the lungs. It helps identify and treat lung and respiratory diseases ranging from asthma to lung cancer.

The company saw its share price explode in 2025 after its flagship product, CT:VQ, received regulatory approvals. It was quickly implemented and adopted through partnerships and commercial contracts with healthcare organisations.

4DMedical has already signed contracts with hospitals and medical providers, primarily across the US. Stanford University, the University of Miami, Cleveland Clinic, and UC San Diego Health have all rolled out the technology at their centres.

So, why are 4DX shares in the spotlight this week?

4DX announced yesterday that its CT:VQ has now been deployed at the Mayo Clinic in the US for ventilation and perfusion analysis. 

The clinic is widely-regarded as one of the world’s leading hospitals. This makes it a landmark moment for 4DX and its shares. 

The news comes amid the company’s rapid repositioning from a research and development business trialling new technology, to a globally commercial business. And this has happened within a very short period of time.

Investors are clearly jumping on board and it is sending the share price flying.

What’s next for 4DX in 2026?

Development and rapid adoption of the company’s technology also mean 4DMedical has smashed its milestone goals this year. 

Approvals have been secured in Canada and New Zealand, and now the company is turning its attention to Europe and Australia.

What’s the outlook for 4DX shares?

The latest share price surge even took analysts by surprise. Despite the majority of brokers holding strong buy ratings, the target prices all now imply a significant downside for 4DX shares from here. We may see analysts confirm or update their expectations for the shares in coming days.

What’s clear though, is that the share price rally demonstrates high expectations for the outlook of the company’s growth. I think we’ll see plenty more from 4DX shares this year.

The post Why is everyone talking about 4DX shares this week? appeared first on The Motley Fool Australia.

More reading

• Forget DroneShield and EOS, this ASX healthcare stock is up 15x in a year!
• Why 4DMedical, Brazilian Rare Earths, Clarity, and Tuas shares are racing higher today
• ASX 300 stock rockets 38% on ‘landmark moment’
• Up over 900%: Is it too late to buy this incredible ASX tech stock?
• Are 4DMedical and Life360 shares a buy, hold or sell after rocketing 10% yesterday?

Motley Fool contributor Samantha Menzies has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.